Regenerative & Repair

TB-500

Thymosin Beta-4 Fragment - Thymosin β-4 fragment studied for actin regulation and tissue repair.

TB-500 is a synthetic version of the naturally occurring peptide Thymosin β-4. Research interest centers on its regulation of actin, cell migration and its reported role in tissue-repair and flexibility models.

As a synthetic form of the naturally occurring Thymosin β-4, TB-500 is studied less for a single receptor and more for its upstream effect on the actin cytoskeleton, which touches migration, angiogenesis and flexibility endpoints. It is a common comparator and combination partner in tissue-repair protocols alongside BPC-157.

TB-500 specifications

CAS number
77591-33-4
Molecular formula
C212H350N56O78S
Molecular weight
4963.44 g/mol
Sequence
Synthetic fragment of Thymosin β-4
Residues
43 residues
Presentation
Lyophilized powder
Documented purity
99.62% by HPLC
Available sizes
10mg ($80)
Archived COA lots
6
Intended use
Laboratory research use only. Not for human or veterinary use.

Studied pathways

  • Actin regulation - Binds and sequesters G-actin, a mechanism linked to cell migration and repair in study models.
  • Cell migration - Studied for its role in directing reparative cells toward sites of tissue stress.

Reported mechanisms in the literature

  • Actin regulation - As a synthetic form of Thymosin β-4, it is studied for binding and sequestering G-actin - a mechanism linked to cell migration and tissue remodeling in repair research. (Goldstein et al.)
  • Reparative cell recruitment - Investigated for directing reparative and endothelial cells toward sites of tissue stress, and for its reported role in flexibility and recovery models. (Sosne et al.)

What TB-500 is researched for

  • Muscle & tendon recovery - Investigated for flexibility and recovery endpoints tied to actin regulation in injury models. (Goldstein et al.)
  • Tissue repair - Studied for reparative cell migration and angiogenesis in cardiac and dermal wound models. (Sosne et al.)
  • Corneal healing - Thymosin β-4 has been studied for corneal wound repair and epithelial migration. (Sosne et al.)

TB-500 certificates of analysis on file

Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.

LotTestedSizeLaboratoryHPLC purityIdentityCertificate
TB-101926-1022 Oct 202610mgILS Laboratories99.36%Confirmed (HPLC retention time)COA PDF
3XWAU312 Sep 202610mgFreedom Diagnostics99.46%Confirmed (LC-MS/MS)COA PDF
C7T15H17 Aug 202610mgFreedom Diagnostics99.17%Confirmed (LC-MS/MS)COA PDF
FD-260527030527 May 202610mgFreedom Diagnostics99.58%Confirmed (LC-MS/MS)COA PDF
60000120 Feb 202610mgFreedom Diagnostics99.86%Confirmed (LC-MS/MS)COA PDF
TB10-12222025-J24 Dec 202510mgFreedom Diagnostics99.72%Confirmed (LC-MS/MS)COA PDF

Published literature on TB-500

The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.

TB-500 frequently asked questions

Is TB-500 the same as Thymosin β-4?

TB-500 is a synthetic version of the naturally occurring peptide Thymosin β-4. Some suppliers instead sell a shorter active fragment; ours is documented on the lot COA. It is a research material only.

Is TB-500 approved for human use?

No. It has no regulatory approval for human use and is not a medicine or supplement. All available data is preclinical. It is supplied for in-vitro laboratory research only.

What is TB-500 studied for?

Chiefly actin regulation, cell migration and tissue-repair signaling in animal and cell models. Findings are preclinical and do not describe effects in humans.

Documented to 99.62% purity by HPLC · third-party COA every lot · from $80 · For laboratory research use only.

Related Regenerative & Repair compounds

  • BPC-157 - Synthetic pentadecapeptide studied for VEGF and growth-factor receptor signaling.
  • BPC-157 / TB-500 - Co-formulated repair-research blend in a single vial.
  • BPC-157 / TB-500 / KPV - BPC-157, TB-500 and KPV co-formulated in a single vial.
  • GHK-Cu - Copper tripeptide studied in skin-remodeling research.
  • KPV - α-MSH C-terminal fragment studied for inflammatory signaling.
  • ARA-290 - Erythropoietin-derived peptide studied for neural repair.
Browse the catalog View the COA library Verify a lot